Medtronic MDT Cash Flow Statement
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| $1.26B+18.7% | $1.15B-11.7% | $1.38B+8.1% | $1.05B-0.2% | $1.06B+60.8% | ||
| $716M-14.8% | $749M+9.5% | $745M+10.4% | $748M+13.0% | $840M+28.4% | ||
| $95M+6.7% | $94M-4.1% | $182M+14.5% | $86M+3.6% | $89M-1.1% | ||
| —— | —— | —— | $167M+89.8% | -$235M+8.9% | ||
| $0— | $0— | $0— | $0— | $0-100% | ||
| $34M+25.9% | $36M-29.4% | $38M+40.7% | $28M+55.6% | $27M-3.6% | ||
| —— | $131M-34.5% | $299M+390% | $373M+71.9% | —— | ||
| $123M-66.4% | $703M+27.8% | -$182M-76.7% | -$598M+1.0% | $366M-43.2% | ||
| —— | —— | $727M+20.0% | $464M+139% | —— | ||
| $287M+15.3% | -$13M-533% | $214M-26.5% | -$288M-162% | $249M-0.8% | ||
| $2.57B+1.8% | $2.74B+6.7% | $925M-3.4% | $1.09B+10.3% | $2.53B-9.0% | ||
| $488M+6.3% | $444M-6.7% | $468M+15.8% | $504M-3.1% | $459M+7.7% | ||
| $406M— | —— | —— | —— | —— | ||
| $2.15B+0.9% | $2.37B+14.3% | $2.1B-1.8% | $2.1B+11.8% | $2.13B-8.3% | ||
| $2.12B-5.2% | $2.02B+5.6% | $1.95B-10.7% | $2.01B-6.8% | $2.24B-2.6% | ||
| —— | $24M-78.6% | -$139M-672% | $125M+635% | $138M+30.2% | ||
| -$917M-87.1% | -$816M+3.2% | -$482M-39.7% | -$719M-178% | -$490M+29.6% | ||
| $908M+1.2% | $911M+1.6% | $910M+1.4% | $910M+1.3% | $897M-1.8% | ||
| $435M+58.8% | $105M-42.0% | $372M+29.2% | $123M-95.1% | $274M-83.2% | ||
| —— | —— | $1.75B— | $0-100% | —— | ||
| —— | —— | $1.77B— | $1.16B— | $0— | ||
| $97M-10.2% | $164M-2.4% | $160M+11.9% | $95M+6.7% | $108M+38.5% | ||
| —— | —— | —— | $70M+567% | -$280M— | ||
| —— | —— | $753M— | $649M+204% | —— | ||
| -$888M+33.9% | -$2.09B-19.1% | -$395M+26.0% | -$1.38B-88.9% | -$1.34B+43.1% | ||
| $33M-88.3% | $24M+118% | —— | $67M+116% | $283M+572% | ||
| —— | -$136M+11.7% | —— | -$945M-3,600% | $978M+388% | ||
| $201M+3.1% | $31M-42.6% | $461M+17.0% | $81M-31.9% | $195M-24.4% | ||
| $344M+13.2% | $204M+13.3% | $992M+5.4% | $402M+2.0% | $304M+38.8% | ||
| $0— | $0— | $0— | $0— | $0-100% | ||
| $287M+15.3% | -$13M-533% | $214M-26.5% | -$288M-162% | $249M-0.8% | ||
| -$34M+88.5% | -$113M-0.9% | -$8M-109% | -$159M-1,867% | -$296M+3.9% | ||
| $34M+25.9% | $36M-29.4% | $38M+40.7% | $28M+55.6% | $27M-3.6% | ||
| —— | $24M-78.6% | -$139M-672% | $125M+635% | $138M+30.2% | ||
| $2.12B-5.2% | $2.02B+5.6% | $1.95B-10.7% | $2.01B-6.8% | $2.24B-2.6% | ||
| $134.5M— | $134.5M— | $134.5M— | $134.5M— | $0— | ||
| —— | $164M-2.4% | $160M+11.9% | $95M+6.7% | $108M+38.5% | ||
| —— | —— | —— | $70M+567% | -$280M— | ||
| —— | —— | $753M— | $649M+204% | —— | ||
| $344M+13.2% | $204M+13.3% | $992M+5.4% | $402M+2.0% | $304M+38.8% | ||
| $2.09B+0.8% | $2.3B+9.7% | $457M-17.5% | $584M+25.3% | $2.07B-12.0% | ||
| $2.09B+0.8% | $2.3B+9.7% | $457M-17.5% | $584M+25.3% | $2.07B-12.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Medtronic generate?
- Medtronic (MDT) generated $7.3B in operating cash flow over the trailing twelve months.
- What is Medtronic's free cash flow?
- After $1.9B of capital expenditures, Medtronic's free cash flow was $5.4B over the trailing twelve months, up 4.7% year over year.
- Where does Medtronic's cash flow data come from?
- Every line is extracted from Medtronic's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
